Przejdź do zawartości
Merck

[Modern approaches to the treatment of biliary pathology in young patients with obesity].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology (2013-02-14)
G Ia Khismatullina, L V Volevach, G A Khakamova, V V Uliamaeva, M A Bychenkova
ABSTRAKT

The therapeutic efficiency of ursosan in 64 overweight patients with chronic noncalculous cholecystitis and dysfunction of biliary tract was evaluated. Including of ursosan in the complex therapy of patients with chronic noncalculous cholecystitis enhances the efficiency of therapy, causes the positive changes in clinical symptoms and indicators of the biliary tract function, diminishes the lithogenic properties of bile, normalize the food behavior.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Ursodeoxycholic acid, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Ursodeoxycholic acid, ≥99%
Ursodeoxycholic acid for system suitability, European Pharmacopoeia (EP) Reference Standard